ESSA Pharma Inc. (EPIX) Tops Q3 EPS by 9c

ESSA Pharma Inc. (NASDAQ: EPIX) reported Q3 EPS of ($0.16), $0.09 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on ESSA Pharma Inc. (EPIX) click here.

You May Also Be Interested In

• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Paramount Skydance clears global regulators for WBD deal, faces state AG suit